{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFigure 6A shows mean serum concentrations of ADG106 in treatment cycle 1 of patients administered 0.03, 0.1, 0.3, 1, 3, 5, or 10mg/kg ADG106 in a U.S. clinical study. \nFigure 6B shows mean serum concentrations of ADG106 in treatment cycle 1 in patients administered 0.1, 0.5, 1.5, 3, 5, or 10mg/kg ADG106 in a chinese clinical study. \nFigure 7 shows the mean serum concentration of ADG106 in male and female cynomolgus monkeys after repeated weekly administrations of 50, 100 or 200mg/kg of ADG 106.\nFIG. 8A shows the kinetics of Ki-67 expression on peripheral CD4+ and CD8+ T cells of R011 administered at a dose of 3mg/kg to a patient weighing 57kg in the case of a total dose of 170mg of ADG106 per cycle. \nFigure 8B shows the kinetics of Ki-67 expression on peripheral CD4+ and CD8+ T cells for treatment with pembrolizumab, 200mg administered at a total dose per cycle.\nFigure 9A shows Ki-67 expression on peripheral CD4+ T cells administered to patients with ADG106 at 0.5mg/kg (n = 1), 1.5mg/kg (n = 5), or 3mg/kg (n = 3), 5mg/kg (n = 4), 10mg/kg (n = 2). \nFig. 9B shows Ki-67 expression on peripheral CD8+ T cells of patients administered ADG106 at 0.5mg/kg (n = 1), 1.5mg/kg (n = 5), 3mg/kg (n = 3), 5mg/kg (n = 4), 10mg/kg (n = 2) and patients administered ADG106 at 0.5mg/kg (n = 1), 1.5mg/kg (n = 5), or 3mg/kg (n = 3). \nFigure 10A shows CD137 expression on peripheral CD4+ T cells of patients administered to ADG106 at 0.5mg/kg (n = 1), 1.5mg/kg (n = 5), 3mg/kg (n = 6), 5mg/kg (n = 8), or 10mg/kg (n = 3). \nFigure 10B shows CD137 expression on peripheral CD8+ T cells of patients administered to ADG106 at 0.5mg/kg (n = 1), 1.5mg/kg (n = 5), 3mg/kg (n = 3), 5mg/kg (n = 8), or 10mg/kg (n = 3).\nFigure 11 shows soluble CD137 (sCD 137) levels before (day 0) and after (days 21, 42, 63, 84, 105, and 126) dosing in patients treated with 1.5, 3, or 5mg/kg ADG106 once every three weeks (Q3W) per cycle."}
{"final_json": [{"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "0.03, 0.1, 0.3, 1, 3, 5, or 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "0.1, 0.5, 1.5, 3, 5, or 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "50, 100 or 200mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "pembrolizumab", "protein_target_name": "Ki-67", "binding_metric": null, "value": "200mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "0.5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "1.5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "Ki-67", "binding_metric": null, "value": "10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "CD137", "binding_metric": null, "value": "0.5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "CD137", "binding_metric": null, "value": "1.5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "CD137", "binding_metric": null, "value": "3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "CD137", "binding_metric": null, "value": "5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "CD137", "binding_metric": null, "value": "10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": "sCD137", "binding_metric": null, "value": "1.5, 3, or 5mg/kg", "unit": "mg/kg", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required. The text appears to describe experimental results, figures, and treatment outcomes, but does not provide the necessary information to extract relevant sentences."}
{"raw_mentions": "There are no sentences that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text appears to be a patent application describing methods of treating cancer using anti-CD137 antibodies, but it does not provide specific bioactivity data."}
{"raw_mentions": "The term \"binding to CD137 (binding to CD 137/bindings to CD 137)\" refers to a binding molecule as defined herein that has an affinity (K) of 100nM or less in an in vitro assay.\nA CD 137-binding molecule is said to specifically bind to human CD137 if it binds to human CD137 with an EC50 that is less than 50% of the EC50 of CD137 of a rat or mouse, as determined in an in vitro assay."}
{"final_json": [{"molecule_name": "CD 137-binding molecule", "protein_target_name": "CD137", "binding_metric": "K", "value": "100", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD 137-binding molecule", "protein_target_name": "CD137", "binding_metric": "EC50", "value": "< 50%", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text primarily lists various molecule names and identifiers, but does not provide corresponding bioactivity metrics or values."}
{"raw_mentions": "There are no sentences that contain all four required components: \n1. A specific molecule name, ID or other identifier.\n2. A bioactivity metric (e.g., IC50, Ki, Kd, EC50, pIC50, pEC50, pKi, pKd).\n3. A specific numeric value for that metric (e.g., \"10\", \"5.5\", \"<100\").\n4. A unit for that value (e.g., \"nM\", \"uM\", \"%\").\n\nThe text provided does not include any sentences that meet these criteria."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some embodiments, the anti-CD 137 antibody is administered at a dose of no more than 500mg (e.g., about 50mg to about 200mg, about 100mg to about 200mg, about 150mg to about 500mg, about 150mg to about 300mg, or about 300mg to about 400mg; e.g., about 50mg, about 100mg, about 200mg, about 300mg, or about 400 mg).\nIn some embodiments, the anti-CD 137 antibody is administered at a dose of about 0.1mg/kg to about 10mg/kg, such as about 3mg/kg to about 8mg/kg, such as about 3mg/kg, About 5mg/kg or about 8 mg/"}
{"final_json": [{"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "500mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "50mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "100mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "200mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "300mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "400mg", "unit": "mg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "0.1mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "5mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "8mg/kg", "unit": "mg/kg", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a specific molecule name, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some embodiments, in a subject who is likely to respond to anti-CD 137 antibody therapy, the level of PD-L1 is reduced by at least about 10%, 20%, 30%, 50%, 60%, 70%, 80%, 90% or more percent after the subject is administered an anti-CD 137 antibody compared to before the subject is administered an anti-CD 137 antibody.\nIn some embodiments, a high level of PD-L1 in the subject prior to administration of the anti-CD 137 antibody as compared to a reference level (e.g., a PD-L1 level in a healthy subject) indicates that the subject is likely to be responsive to treatment with the anti-CD 137 antibody, e.g., the subject is likely to have stable disease, with the high level being at least about any of 50%, 100%, 150%, 2-fold, 2.5-fold, 3-fold, 4-fold, 5-fold, or more compared to a reference level.\nIn some embodiments, in a subject likely to respond to treatment with an anti-CD 137 antibody, the level of Ki67 is increased by at least about 10%, 20%, 30%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, 2-fold, 2.5-fold, 3-fold, 4-fold, 5-fold, or more after the subject is administered an anti-CD 137 antibody compared to before the subject is administered an anti-CD 137 antibody."}
{"final_json": [{"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "10%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "20%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "30%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "50%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "60%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "70%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "80%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "90%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "100%", "unit": "%", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "50%", "unit": "%", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "100%", "unit": "%", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "150%", "unit": "%", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "2-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "2.5-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "3-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "4-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "PD-L1", "binding_metric": null, "value": "5-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "10%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "20%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "30%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "50%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "60%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "70%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "80%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "90%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "100%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "150%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "2-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "2.5-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "3-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "4-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD 137", "binding_metric": null, "value": "5-fold", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "In some embodiments, the anti-CD 137 antibody specifically binds human CD137 with a KD of about 500nM or less (e.g., about 500nM or less, about 400nM or less, about 300nM or less, about 200nM or less, about 150nM or less, about 100nM or less, about 90nM or less, about 80nM or less, about 75nM or less, about 70nM or less, about 60nM or less, about 50nM or less, about 40nM or less, about 30nM or less, about 25nM or less, about 20nM or less, about 10nM or less, about 1nM or less, about 0.1nM or less, etc.).\nIn some embodiments, the anti-CD 137 antibody specifically binds to human CD137 with a KD of about 100nM or less.\nIn some embodiments, the anti-CD 137 antibody specifically binds to human CD137 with a KD of about 50nM or less."}
{"final_json": [{"molecule_name": "anti-CD 137 antibody", "protein_target_name": "human CD137", "binding_metric": "KD", "value": "500nM or less", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "human CD137", "binding_metric": "KD", "value": "100nM or less", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "human CD137", "binding_metric": "KD", "value": "50nM or less", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "In some embodiments, an anti-CD 137 antibody has a half maximal inhibitory concentration (IC 50) of about 500nM or less (e.g., about 500nM or less, about 400nM or less, about 300nM or less, about 200nM or less, about 100nM or less, about 50nM or less, about 25nM or less, about 10nM or less, about 1nM or less, etc.) for blocking the binding of CD137 to its ligand.\nIn some embodiments, the anti-CD 137 antibody has a half maximal inhibitory concentration (IC 50) of about 100nM or less for blocking the binding of CD137 to its ligand.\nIn some embodiments, the anti-CD 137 antibody completely blocks binding of human CD137 to its ligand when provided at a concentration of about 100nM or greater (e.g., about 100nM or greater, about 500nM or greater, about 1 \u03bc\u039c or greater, about 10 \u03bc\u039c or greater, etc.)."}
{"final_json": [{"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD137", "binding_metric": "IC 50", "value": "<=500nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD137", "binding_metric": "IC 50", "value": "<=100nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD 137 antibody", "protein_target_name": "CD137", "binding_metric": null, "value": ">=100nM", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a specific molecule name, bioactivity metric, numeric value, and unit."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required. The text appears to describe methods and embodiments related to cancer treatment and biomarkers, but it does not provide the necessary information to extract relevant sentences."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nReceptor occupancy was estimated according to the following formula based on the determination of binding affinities (KD) for ADG106 (3.7 nM), wu Ruilu mab (9.6 nM), and Wu Tuolu mab (20.9 nM) by Surface Plasmon Resonance (SPR): receptor occupancy% = [ drug plasma concentration ]/([ drug plasma concentration ] + KD) x 100.\nAs shown in FIG. 5, the estimated receptor occupancy of ADG106 was 58% at 0.03mg/kg, 82% at 0.1mg/kg, 93% at 0.3mg/kg, and 98% at the 1mg/kg dose level.\nAs shown in Table 8, receptor occupancy of Wu Ruilu mab at its maximum tolerated clinical dose (MTD, 0.1 mg/kg) was estimated to be 64%, while Wu Tuolu mab at its maximum clinically administered dose (MAD, 10 mg/kg) was estimated to be 98%."}
{"final_json": [{"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": "KD", "value": "3.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "wu Ruilu mab", "protein_target_name": null, "binding_metric": "KD", "value": "9.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Wu Tuolu mab", "protein_target_name": null, "binding_metric": "KD", "value": "20.9", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "58", "unit": "%", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "82", "unit": "%", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "93", "unit": "%", "is_logarithmic": false}, {"molecule_name": "ADG106", "protein_target_name": null, "binding_metric": null, "value": "98", "unit": "%", "is_logarithmic": false}, {"molecule_name": "Wu Ruilu mab", "protein_target_name": null, "binding_metric": null, "value": "64", "unit": "%", "is_logarithmic": false}, {"molecule_name": "Wu Tuolu mab", "protein_target_name": null, "binding_metric": null, "value": "98", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text primarily discusses the effects of ADG106 treatment on immune responses and biomarkers, but does not provide specific bioactivity metrics with numeric values and units."}
{"raw_mentions": "There are no sentences that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
